Lumacaftor - Wikipedia
Lumacaftor (VX-809) is a pharmaceutical drug that acts as a chaperone during protein folding and increases the number of CFTR proteins that are trafficked to the cell surface. [1]
Lumacaftor and ivacaftor (oral route) - Mayo Clinic
2024年10月1日 · Lumacaftor and ivacaftor combination is used to treat cystic fibrosis (CF) in patients 1 year of age and older. It is only used for patients who have two copies of F508del …
Ivacaftor and lumacaftor Uses, Side Effects & Warnings
Ivacaftor and lumacaftor is a combination medicine used to treat cystic fibrosis in adults and children who are at least 1 year old. Ivacaftor and lumacaftor tablet can be used in children …
Lumacaftor and Ivacaftor: MedlinePlus Drug Information
Lumacaftor and ivacaftor is used to treat certain types of cystic fibrosis (an inborn disease that causes problems with breathing, digestion, and reproduction) in adults and children 1 year of …
ORKAMBI® (lumacaftor/ivacaftor) | Patient Information
ORKAMBI ® (lumacaftor/ivacaftor) is a prescription medicine used for the treatment of cystic fibrosis (CF) in patients aged 1 year and older who have two copies of the F508del mutation …
Lumacaftor/ivacaftor - Wikipedia
Lumacaftor/ivacaftor, sold under the brand name Orkambi among others, is a combination of lumacaftor and ivacaftor used to treat people with cystic fibrosis who have two copies of the …
Lumacaftor: Uses, Interactions, Mechanism of Action ...
Lumacaftor is a protein chaperone used in combination with ivacaftor for the treatment of cystic fibrosis in patients who are homozygous for the F508del mutation in the CFTR gene.
- 某些结果已被删除